Wilson Sonsini Goodrich & Rosati advised Ji Xing Pharmaceuticals Limited (JIXING) on the transaction. TMS Co., Ltd. (TMS) and Ji Xing Pharmaceuticals Limited (JIXING) announced that...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Foresight Diagnostics on the transaction. Allogene Therapeutics Inc. (Nasdaq: ALLO) and Foresight Diagnostics, announced a strategic partnership to develop a minimal residual...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Droplet Biosciences on the deal. Droplet Biosciences announced an $8 million seed investment to establish proof of concept for the company’s lymph diagnostic...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ascidian Therapeutics on the deal. Life sciences venture capital firm ATP announced the launch of new biotechnology company Ascidian Therapeutics....
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Zai Lab Limited on the deal. Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) announced its broad strategic collaboration and license agreement with MacroGenics...
You must be a Standard 1 Year member to access this content.
